Hirata K, Kume S, Araki S, Sakaguchi M, Chin-Kanasaki M, Isshiki K, Sugimoto T, Nishiyama A, Koya D, Haneda M, et al: Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model
Since its release, Health Canada has expanded Wegovys approval to include cardiovascular risk reduction in adults with established heart disease
Around the same time, the Food and Drug Administration (FDA) in the United States and the Medicines and Healthcare Product Regulatory Agency (MHRA) in the United Kingdom undertook similar evaluations
Construction and performance of exendin-4-loaded chitosan-PLGA microspheres for enhancing implant osseointegration in type 2 diabetic rats
September 2025: First enforcement wave
By enhancing these natural processes, GLP-1 medications help you feel full sooner, reduce cravings, and maintain steadier energy throughout the day